RTP biotech targeting stroke treatments raises $27.5M, Business NC reports
A Research Triangle Park-based biotechnology company working on a drug to treat strokes has raised $27.5 million from investors. Here are the details.
Read More
basking biosciences
RTP startup targeting stroke treatment raises $1.9M, wants another $5M
Life science startup Basking Biosciences, which is developing what it believes will be a reversible anti-thrombotic therapeutic to treat ischemic stroke, has closed on $1.9 million in financing and is seeking more.
Read More
